v3.26.1
Stockholders’ Equity (Tables)
 3 Months Ended
Mar. 31, 2026
Stockholders’ Equity [Line Items]  
Schedule of Preferred Stock Outstanding

All series of the Company’s convertible preferred stock include alternate conversion provisions. The Company’s convertible preferred stock also contains floor pricing provisions; the Company has the discretion to issue shares below the floor price.

 

Aditxt Preferred Share Class  Quantity
Issued and
Outstanding
as of
March 31,
2026		   Standard
Conversion
Common
Stock
Equivalent		   Liquidation
Amount		 
Series A Preferred Stock   
-
    
-
   $
-
 
Series A-1 Convertible Preferred Stock1   20,552    1,103,165    25,689,940 
Series A-2 Convertible Preferred Stock   36,000    488,222    36,000,000 
Series B Preferred Stock   
-
    
-
    
-
 
Series B-1 Convertible Preferred Stock   2,689    144,338    3,361,250 
Series B-2 Convertible Preferred Stock   2,625    140,902    3,281,250 
Series C Preferred Stock   
-
    
-
    
-
 
Series C-1 Convertible Preferred Stock1   896    48,107    1,120,290 
Series D-1 Preferred Stock   
-
    
-
    
-
 
Total Aditxt Preferred Shares Outstanding   62,762    1,924,734   $69,452,730 
Schedule of Stock Option Grant Activity Plan

The following is an analysis of the stock option grant activity under the Plan:

 

Vested and Nonvested Stock Options  Number   Weighted
Average
Exercise
Price		   Weighted
Average
Remaining
Life		 
Outstanding December 31, 2025   55   $669,091,001,105.46    5.72 
Granted   
-
    
-
    - 
Exercised   
-
    
-
    - 
Expired or forfeited   
-
    
-
    - 
Outstanding March 31, 2026   55   $669,091,001,105.46    5.48 

The following is an analysis of the stock option grant activity under the Pearsanta Plans:

 

Vested and Nonvested Stock Options   Number     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Life		  
Outstanding December 31, 2025     181,227     $ 1.19       7.84  
Granted     -       -       -  
Exercised     -       -       -  
Expired or forfeited     -       -       -  
Rounding in connection with Reverse Split     -       -       -  
Outstanding March 31, 2026     181,227     $ 1.19       7.59  

A summary of warrant issuances are as follows:

 

Vested and Nonvested Warrants  Number   Weighted
Average
Exercise
Price		   Weighted
Average
Remaining
Life		 
Outstanding December 31, 2025   77   $19,764,861,421.50    1.49 
Granted   
-
    
-
    
-
 
Issued due to resets   698,798    18.63    3.24 
Exercised   
-
    
-
    - 
Expired or forfeited   (4)   1,952,640,000,000.00    - 
Outstanding March 31, 2026   698,871   $9,068,800.72    3.24 
Schedule of Nonvested Stock Options
Nonvested Stock Options  Number   Weighted-
Average
Exercise
Price		 
Nonvested on December 31, 2025   
         -
   $
          -
 
Granted   
-
    
-
 
Vested   
-
    
-
 
Forfeited   
-
    
-
 
Nonvested on March 31, 2026   
-
   $
-
 
Nonvested Stock Options     Number       Weighted-
Average
Exercise
Price		  
Nonvested on December 31, 2025     -     $ -  
Granted     -       -  
Vested     -       -  
Forfeited               -                -  
Nonvested on March 31, 2026     -     $ -  
Nonvested Warrants  Number   Weighted-
Average
Exercise
Price		 
Nonvested on December 31, 2025   -   $- 
Granted   
-
    
-
 
Issued due to resets   18,868,057    18.63 
Vested   (18,868,057)   18.63 
Forfeited   
-
    
-
 
Nonvested on March 31, 2026   
-
   $
-
 
Schedule of Fair Value of Warrant Granted

For the three months ended March 31, 2026, the fair value of each warrant granted was estimated using the assumption and/or factors in the Black-Scholes Model as follows:

 

Exercise price  $18.63 
Expected dividend yield   0%
Risk free interest rate   3.81%
Expected life in years   2.09-3.36 
Expected volatility   189-190%